Drugs / WRSS1
WRSS1
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02934178 | Feb 2017 → Jan 2018 | diarrheal disease | PATH | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01080716 | May → Sep 2010 | shigellosis | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01813071 | Aug 2013 → Apr 2016 | diarrheal disease | PATH | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WRSS1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01813071 ↗ |
| Known as | Shigella sonnei Strain WRSS1 Vaccine | “Shigella sonnei Strain WRSS1 Vaccine” NCT02934178 ↗ |
| Known as | Shigella WRSS1 vaccine | “Live attenuated, oral Shigella WRSS1 vaccine” NCT02934178 ↗ |
| Known as | Walter Reed S. sonnei | “This is a research study about an experimental (investigational) oral Shigella sonnei - Walter Reed S. sonnei (WRSS1).” NCT01813071 ↗ |
| Modality | Vaccine | “Live attenuated Shigella sonnei vaccine candidate WRSS1” PMID 27146000 ↗ Jul 2016 |
| Route | Oral | “participants received a single oral dose of 1.6 × 10(4) CFU of WRSS1” PMID 27146000 ↗ Jul 2016 |